VCG
ANGO icon

Vantage Consulting Group’s AngioDynamics ANGO Stock Holding History

Vantage Consulting Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-853
Closed -$13K – 192
2020
Q4 		$13K Buy
+853
New +$10.8K ﹤0.01% 1061

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Vantage Consulting Group's ANGO Position: Q1 2021 in Review

Vantage Consulting Group sold out of AngioDynamics (ANGO) in Q1 2021, closing a stake of 853 shares — an estimated $13K sold.

Vantage Consulting Group first reported a position in ANGO in Q4 2020 and held it in 1 quarter. The position peaked at $13K in Q4 2020. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2021.

  • Vantage Consulting Group reported no remaining AngioDynamics position as of Q1 2021 after selling out during the quarter.
  • Vantage Consulting Group sold 853 AngioDynamics shares in Q1 2021, an estimated $13K.
  • Vantage Consulting Group first reported a position in AngioDynamics in Q4 2020 and held it in 1 quarter.
  • Vantage Consulting Group's AngioDynamics position peaked at $13K in Q4 2020.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.